MELANIE HASHAGEN: Open Payments
NPI 1871060053 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 36 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $349 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $233 |
| Edwards Lifesciences Corporation | 2 | $162 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $126 |
| Novo Nordisk Inc | 5 | $113 |
| Bausch Health US, LLC | 3 | $68 |
| Kowa Pharmaceuticals America, Inc. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Hologic Sales and Service, LLC | 1 | $31 |
Products named: CAPLYTA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), APLENZIN, ZORYVE, Mirena, SPRAVATO, GVOKE HYPOPEN, THINPREP 2000 PROCESSOR.
Industry payments across TX — which companies pay providers there.
